Learn more on this topic: Risk-Adapted Treatment of Indolent B-Cell Lymphomas: Application of Novel Agents

What are the latest data on newly approved agents for primary, relapsed, and refractory follicular lymphoma?

Amy Goodrich, MSN, CRNP

Amy Goodrich, MSN, CRNP, on treating follicular lymphoma.

Copyright © 2010-2020 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.